T.Kawabe & Co., Ltd.
T.Kawabe & Co., Ltd. (8123.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for T.Kawabe & Co., Ltd. (8123.T), covering cash flow, earnings, and balance sheets.
T.Kawabe & Co., Ltd. (8123.T) Income Statement & Financial Overview
View the income breakdown for T.Kawabe & Co., Ltd. 8123.T across both annual and quarterly reports.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $3.57B | $3.61B | $2.88B | $2.72B |
Cost of Revenue | $2.09B | $2.07B | $1.70B | $1.65B |
Gross Profit | $1.48B | $1.54B | $1.18B | $1.07B |
Gross Profit Ratio | $0.41 | $0.43 | $0.41 | $0.39 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.18B | $1.31B | $1.18B | $1.25B |
Operating Expenses | $1.18B | $1.31B | $1.18B | $1.25B |
Total Costs & Expenses | $3.27B | $3.38B | $2.88B | $2.90B |
Interest Income | $394000.00 | $2000.00 | $185000.00 | $2.00M |
Interest Expense | $7.69M | $0.00 | $6.29M | $0.00 |
Depreciation & Amortization | $48.15M | $43.92M | $42.70M | $43.50M |
EBITDA | $360.80M | $271.50M | $39.00M | -$141.50M |
EBITDA Ratio | $0.10 | $0.08 | $0.01 | -$0.05 |
Operating Income | $295.62M | $227.00M | -$3.00M | -$185.00M |
Operating Income Ratio | $0.08 | $0.06 | -$0.001 | -$0.07 |
Other Income/Expenses (Net) | -$12.57M | $35.00M | $30.00M | $25.00M |
Income Before Tax | $283.04M | $262.00M | $27.00M | -$160.00M |
Income Before Tax Ratio | $0.08 | $0.07 | $0.009 | -$0.06 |
Income Tax Expense | $81.41M | $64.00M | -$170.38M | $24.00M |
Net Income | $201.63M | $198.00M | $196.00M | -$184.00M |
Net Income Ratio | $0.06 | $0.05 | $0.07 | -$0.07 |
EPS | $110.15 | $108.50 | $107.39 | -$100.81 |
Diluted EPS | $110.15 | $108.50 | $107.39 | -$100.81 |
Weighted Avg Shares Outstanding | $1.82M | $1.82M | $1.83M | $1.83M |
Weighted Avg Shares Outstanding (Diluted) | $1.82M | $1.82M | $1.83M | $1.83M |
Over the past four quarters, T.Kawabe & Co., Ltd. demonstrated steady revenue growth, increasing from $2.72B in Q1 2024 to $3.57B in Q4 2024. Operating income reached $295.62M in Q4 2024, maintaining a consistent 8% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $360.80M, reflecting operational efficiency. Net income rose to $201.63M, with EPS at $110.15. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan